Phathom Pharmaceuticals
- Biotech or pharma, therapeutic R&D
Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for gastrointestinal (GI) diseases. We have licensed the exclusive rights in the United States, Europe, and Canada to a potassium-competitive acid blocker (PCAB), which the company has been developing for the treatment of certain GI disorders.